NCT03888365 Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH Status COMPLETED Phase N/A
NCT03884465 Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil Status TERMINATED Phase PHASE2
NCT03863990 Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs Status COMPLETED Phase N/A
NCT03841344 Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH Status UNKNOWN Phase NA
NCT03838445 Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) Status RECRUITING Phase NA
NCT03819777 Volatile Organic Compounds (VOCs) as a Biomarker in Immune-mediated Pulmonary Arterial Hypertension (PAH) Status UNKNOWN Phase N/A
NCT03810443 Prevalence of the Hyperventilation Syndrome in Pulmonary Arterial Hypertension Status UNKNOWN Phase NA
NCT03795428 Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 Status TERMINATED Phase PHASE2
NCT03789643 Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension Status WITHDRAWN Phase PHASE2
NCT03744637 A Study of Single Doses of Frespaciguat (MK-5475) on Pulmonary Vascular Resistance (MK-5475-002) Status COMPLETED Phase PHASE1
NCT03738150 A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2
NCT03718780 Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise Status UNKNOWN Phase NA
NCT03708146 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 5-1058 Status COMPLETED Phase PHASE1
NCT03683186 A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension Status ENROLLING_BY_INVITATION Phase PHASE3
NCT03657095 A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension Status TERMINATED Phase PHASE3
NCT03655704 Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study Status COMPLETED Phase EARLY_PHASE1